Expert Opinion on Drug Safety

Publisher
Routledge, Taylor & Francis
 
 
ZDB-ID
 

1-3 of 3
 
Check/Uncheck all
  • 2020 Journal Article | Research Paper
    ​ ​19th Annual Meeting of the Safety Pharmacology Society: regulatory and safety perspectives for advanced therapy medicinal products (cellular and gene therapy products)​
    Cavero, I.; Seimetz, D.; Koziel, D.; Zimmermann, W.-H.   & Holzgrefe, H. H.​ (2020) 
    Expert Opinion on Drug Safety19(5) pp. 553​-558​.​ DOI: https://doi.org/10.1080/14740338.2020.1741546 
    Details  DOI  PMID  PMC 
  • 2010 Review
    ​ ​Bladder symptoms in multiple sclerosis: a review of pathophysiology and management​
    Nicholas, R.; Young, C. A.& Friede, T.​ (2010)
    Expert Opinion on Drug Safety, 9​(6) pp. 905​-915​.​
    Informa Healthcare. DOI: https://doi.org/10.1517/14740338.2010.501793 
    Details  DOI  PMID  PMC  WoS 
  • 2005 Journal Article
    ​ ​The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder​
    Himpel, S.; Banaschewski, T.; Heise, C.-A. & Rothenberger, A.​ (2005) 
    Expert Opinion on Drug Safety4(2) pp. 311​-321​.​ DOI: https://doi.org/10.1517/14740338.4.2.311 
    Details  DOI 

Type

Subtype

Date issued

Publication Affiliation

Fulltext

Options

Citation Style

Sort

Issue Date
Title

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.